Symbol | Exchange | Currency |
|---|
Aridis Pharmaceuticals, Inc. (Nasdaq: NASDAQ:ARDS), a biopharmaceutical company, today announced that it has entered into a definitive agreement for the issuance and sale of an...
Aridis Pharmaceuticals, Inc. (Nasdaq: NASDAQ:ARDS) today announced preliminary top-line results from the randomized, double blinded, placebo-controlled Phase 2a study of AR-501,...
As of late, it has definitely been a great time to be an investor in Aridis Pharmaceuticals Inc. (NASDAQ:ARDS) . The stock has moved higher by 31.7% in the past month, while it is...
Aridis Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is focused on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAbs) to treat life-threatening infections. The Company's product pipeline is comprised of fully human mAbs targeting specific pathogens associated with life-threatening bacterial and viral infections, primarily hospital-acquired pneumonia (HAP), ventilator-associated pneumonia (VAP), cystic fibrosis and COVID-19. The Company's lead product candidate, AR-301, targets the alpha toxin produced by gram-positive bacteria Staphylococcus aureus (S. aureus), a common pathogen associated with HAP and VAP. Its clinical development activities are focused on AR-301, AR320, AR-701, and AR-501. Its MabIgX and lPEX discovery platforms enables the Company to rapidly screen, identify and optimize fully human therapeutic mAb product candidates directly from the B-cells of patients.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Neutral | Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Buy | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Neutral | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 193.88 | 195.29 | 189.44 | +4.69 | +2.48% | 122.89M | NASDAQ | |||
| 160.77 | 161.05 | 159.35 | +3.12 | +1.98% | 50.34M | NASDAQ | |||
| 61.86 | 61.95 | 61.59 | +0.44 | +0.72% | 9.29M | NYSE | |||
| 205.35 | 205.72 | 202.54 | +4.67 | +2.33% | 18.70M | NASDAQ | |||
| 101.39 | 102.49 | 100.65 | +0.36 | +0.36% | 28.63M | NASDAQ | |||
| 280.51 | 281.14 | 278.41 | +5.28 | +1.92% | 24.62M | NASDAQ | |||
| 40.25 | 40.27 | 39.99 | +0.26 | +0.65% | 14.37M | NYSE | |||
| 96.09 | 96.91 | 94.87 | +1.53 | +1.62% | 55.19M | NASDAQ | |||
| 100.25 | 100.42 | 98.56 | +3.01 | +3.10% | 49.41M | NASDAQ | |||
| 162.13 | 162.68 | 160.15 | +3.15 | +1.98% | 1.74M | NASDAQ | |||
| 269.84 | 270.78 | 265.97 | +5.74 | +2.17% | 38.61M | NASDAQ | |||
| 8.22 | 8.25 | 8.05 | +0.22 | +2.75% | 15.23M | NYSE | |||
| 101.90 | 102.82 | 101.03 | +0.54 | +0.53% | 26.02M | NASDAQ | |||
| 46.70 | 46.73 | 44.75 | +2.39 | +5.39% | 14.19M | NYSE | |||
| 10.28 | 10.28 | 10.26 | +0.010 | +0.10% | 6.34K | NYSE |